Responses and advisability of active surveillance in prostate cancer (in response to editorial comments by Dr. Sánchez Badajoz)

Actas Urol Esp. 2016 Mar;40(2):72-4. doi: 10.1016/j.acuro.2015.08.005. Epub 2015 Oct 9.

[Article in English, Spanish]

Authors

J Rubio-Briones¹, Á Borque Fernando²

Affiliations

¹ Servicio de Urología, Instituto Valenciano de Urología, Valencia, España.
² Servicio de Urología, Hospital Universitario Miguel Servet, Zaragoza, España. Electronic address: aborque@comz.org.

PMID: 26454355
DOI: 10.1016/j.acuro.2015.08.005

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Male
Prostate-Specific Antigen*
Prostatic Neoplasms / epidemiology*
Watchful Waiting

Substances

Prostate-Specific Antigen